Method for preparing oligodendrocytes and use
AssigneeShenzhen ExoNeuglia Biomedical Technology Co., Ltd.
InventorsYing GUO, Hong GAO
Life of this patent
Estimating the term…
Loading patent…
AssigneeShenzhen ExoNeuglia Biomedical Technology Co., Ltd.
InventorsYing GUO, Hong GAO
Estimating the term…
A method of producing oligodendrocytes recapitulates the major steps of oligodendrocyte differentiation in a significantly shorter time than the 75-95 days required for the previous protocol. The cannabinoid receptor agonist, WIN55212-2, induces NSC differentiation and promotes OLIG2+OPC induction. WIN-derived OLIG2+ progenitor cells differentiate into PDGFR α+ OPCs, which are highly migratory, can further differentiate into mature OLs with strong myelination ability. When WIN-derived OPCs were transplanted to the lesion site, the motor ability of spinal cord injury (SCI) mice was significantly improved from the second week after transplantation. Immunostaining results showed that WIN-derived OPCs could differentiate into mature OLs and myelinate injured axons. The method and product have wide applications in the field of cellular therapy, especially for spinal cord injury with remarkable therapeutic effects.
-19. (canceled)
A method for producing oligodendrocytes, comprising:
A method for promoting neural stem cell differentiation into oligodendrocytes, comprising the method for producing oligodendrocytes according to claim 2l .
Dependencies are inferred from the claim text.